125 related articles for article (PubMed ID: 33187456)
1. Neurotoxicity of poly(propylene imine) glycodendrimers.
Franiak-Pietryga I; Ziemba B; Sikorska H; Jander M; Appelhans D; Bryszewska M; Borowiec M
Drug Chem Toxicol; 2022 Jul; 45(4):1484-1492. PubMed ID: 33187456
[TBL] [Abstract][Full Text] [Related]
2. The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI.
Franiak-Pietryga I; Ziółkowska E; Ziemba B; Appelhans D; Voit B; Szewczyk M; Góra-Tybor J; Robak T; Klajnert B; Bryszewska M
Mol Pharm; 2013 Jun; 10(6):2490-501. PubMed ID: 23641871
[TBL] [Abstract][Full Text] [Related]
3. Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.
Ziemba B; Franiak-Pietryga I; Pion M; Appelhans D; Muñoz-Fernández MÁ; Voit B; Bryszewska M; Klajnert-Maculewicz B
Int J Pharm; 2014 Jan; 461(1-2):391-402. PubMed ID: 24361266
[TBL] [Abstract][Full Text] [Related]
4. Interaction study between maltose-modified PPI dendrimers and lipidic model membranes.
Wrobel D; Appelhans D; Signorelli M; Wiesner B; Fessas D; Scheler U; Voit B; Maly J
Biochim Biophys Acta; 2015 Jul; 1848(7):1490-501. PubMed ID: 25843678
[TBL] [Abstract][Full Text] [Related]
5. Internalization and intracellular trafficking of poly(propylene imine) glycodendrimers with maltose shell in melanoma cells.
Filimon A; Sima LE; Appelhans D; Voit B; Negroiu G
Curr Med Chem; 2012; 19(29):4955-68. PubMed ID: 23033945
[TBL] [Abstract][Full Text] [Related]
6. Modulation of biogenic amines content by poly(propylene imine) dendrimers in rats.
Ciepluch K; Ziemba B; Janaszewska A; Appelhans D; Klajnert B; Bryszewska M; Fogel WA
J Physiol Biochem; 2012 Sep; 68(3):447-54. PubMed ID: 22371014
[TBL] [Abstract][Full Text] [Related]
7. Effect of poly(propylene imine) glycodendrimers on β-amyloid aggregation in vitro and in APP/PS1 transgenic mice, as a model of brain amyloid deposition and Alzheimer's disease.
Klementieva O; Aso E; Filippini D; Benseny-Cases N; Carmona M; Juvés S; Appelhans D; Cladera J; Ferrer I
Biomacromolecules; 2013 Oct; 14(10):3570-80. PubMed ID: 24004423
[TBL] [Abstract][Full Text] [Related]
8. Gd-Chelated poly(propylene imine) dendrimers with densely organized maltose shells for enhanced MR imaging applications.
Xiong Z; Wang Y; Zhu J; He Y; Qu J; Effenberg C; Xia J; Appelhans D; Shi X
Biomater Sci; 2016 Oct; 4(11):1622-1629. PubMed ID: 27722500
[TBL] [Abstract][Full Text] [Related]
9. Genotoxicity of poly(propylene imine) dendrimers.
Ziemba B; Matuszko G; Appelhans D; Voit B; Bryszewska M; Klajnert B
Biopolymers; 2012 Aug; 97(8):642-8. PubMed ID: 22605555
[TBL] [Abstract][Full Text] [Related]
10. Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL.
Franiak-Pietryga I; Ziemba B; Sikorska H; Jander M; Kuncman W; Danilewicz M; Appelhans D; Lewkowicz P; Ostrowska K; Bryszewska M; Borowiec M
Toxicol Appl Pharmacol; 2020 Sep; 403():115139. PubMed ID: 32687837
[TBL] [Abstract][Full Text] [Related]
11. Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency.
Schmitz M; Candelise N; Kanata E; Llorens F; Thüne K; Villar-Piqué A; da Silva Correia SM; Dafou D; Sklaviadis T; Appelhans D; Zerr I
Mol Neurobiol; 2020 Apr; 57(4):1863-1874. PubMed ID: 31848935
[TBL] [Abstract][Full Text] [Related]
12. Sugar-Modified Poly(propylene imine) Dendrimers Stimulate the NF-κB Pathway in a Myeloid Cell Line.
Jatczak-Pawlik I; Gorzkiewicz M; Studzian M; Appelhans D; Voit B; Pulaski L; Klajnert-Maculewicz B
Pharm Res; 2017 Jan; 34(1):136-147. PubMed ID: 27766462
[TBL] [Abstract][Full Text] [Related]
13. Structural dependence of in vitro cytotoxicity, oxidative stress and uptake mechanisms of poly(propylene imine) dendritic nanoparticles.
Khalid H; Mukherjee SP; O'Neill L; Byrne HJ
J Appl Toxicol; 2016 Mar; 36(3):464-73. PubMed ID: 26671548
[TBL] [Abstract][Full Text] [Related]
14. In vivo toxicity of poly(propyleneimine) dendrimers.
Ziemba B; Janaszewska A; Ciepluch K; Krotewicz M; Fogel WA; Appelhans D; Voit B; Bryszewska M; Klajnert B
J Biomed Mater Res A; 2011 Nov; 99(2):261-8. PubMed ID: 21976451
[TBL] [Abstract][Full Text] [Related]
15. Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers.
Agashe HB; Babbar AK; Jain S; Sharma RK; Mishra AK; Asthana A; Garg M; Dutta T; Jain NK
Nanomedicine; 2007 Jun; 3(2):120-7. PubMed ID: 17572354
[TBL] [Abstract][Full Text] [Related]
16. Influence of fourth generation poly(propyleneimine) dendrimers on blood cells.
Ziemba B; Halets I; Shcharbin D; Appelhans D; Voit B; Pieszynski I; Bryszewska M; Klajnert B
J Biomed Mater Res A; 2012 Nov; 100(11):2870-80. PubMed ID: 22623362
[TBL] [Abstract][Full Text] [Related]
17. Stability of dendriplexes formed by anti-HIV genetic material and poly(propylene imine) dendrimers in the presence of glucosaminoglycans.
Szewczyk M; Drzewinska J; Dzmitruk V; Shcharbin D; Klajnert B; Appelhans D; Bryszewska M
J Phys Chem B; 2012 Dec; 116(50):14525-32. PubMed ID: 23199071
[TBL] [Abstract][Full Text] [Related]
18. Sugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance.
Szulc A; Pulaski L; Appelhans D; Voit B; Klajnert-Maculewicz B
Int J Pharm; 2016 Nov; 513(1-2):572-583. PubMed ID: 27667754
[TBL] [Abstract][Full Text] [Related]
19. Poly(propylene imine) dendrimers modified with maltose or maltotriose protect phosphorothioate oligodeoxynucleotides against nuclease activity.
Drzewińska J; Appelhans D; Voit B; Bryszewska M; Klajnert B
Biochem Biophys Res Commun; 2012 Oct; 427(1):197-201. PubMed ID: 22995301
[TBL] [Abstract][Full Text] [Related]
20. Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes).
Tack F; Bakker A; Maes S; Dekeyser N; Bruining M; Elissen-Roman C; Janicot M; Brewster M; Janssen HM; De Waal BF; Fransen PM; Lou X; Meijer EW
J Drug Target; 2006 Feb; 14(2):69-86. PubMed ID: 16608734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
